U.S. Device Maker Cook Expands Line In Japan, Revises Techniques
This article was originally published in PharmAsia News
Executive Summary
U.S. medical device maker Cook Medical has decided to sell its wares directly to medical facilities in Japan instead of relying on sales agents as it moves to strengthen its market in the country. As part of the effort, Cook recently hired 15 medical representatives and marketers and formed a 10-person team to oversee clinical tests and shepherd products through the approval process. A new drug-eluting stent already is being tested in Japan as well as the U.S. The firm plans to begin developing for the Japanese market products already selling in the U.S. and Europe. (Click here for more - a subscription may be required
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.